GenSight Logo
Login

Credits

Data sources and attribution

Last updated: 2 November 2026

GenSight (Genassis Insights) is built on public and licensed data from the organisations below. Genassis processes, normalises and links this data. It is not an official record of any of these organisations, and none of them endorses GenSight.

Mondo Disease Ontology

Attribution required · CC BY 4.0

Disease identifiers (MONDO ids) and names used to link conditions across sources.

Data from Mondo Disease Ontology (https://mondo.monarchinitiative.org), release 2026-09-01, licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Genassis has processed and linked this data; changes were made. Not endorsed by the Monarch Initiative.

https://mondo.monarchinitiative.org/

Medical Subject Headings (MeSH)

Attribution required · NLM terms and conditions for downloaded data

Medical vocabulary used to name and group conditions and topics.

Courtesy of the U.S. National Library of Medicine.

https://www.nlm.nih.gov/databases/download/terms_and_conditions.html

ClinicalTrials.gov

Attribution required · ClinicalTrials.gov Terms and Conditions

Clinical trial registrations and results.

Source: ClinicalTrials.gov (U.S. National Library of Medicine). Genassis has processed, normalised and linked this data; it is not an official ClinicalTrials.gov record.

https://clinicaltrials.gov/about-site/terms-conditions

PubMed

Attribution required · NLM terms and conditions for downloaded data

Titles, abstracts and bibliographic records of published literature.

Courtesy of the U.S. National Library of Medicine. Abstracts may be protected by copyright held by journal publishers or authors.

https://www.nlm.nih.gov/databases/download/terms_and_conditions.html

DailyMed

Attribution required · NLM terms and conditions for downloaded data

US product labels.

Courtesy of the U.S. National Library of Medicine.

https://www.nlm.nih.gov/databases/download/terms_and_conditions.html

openFDA

Credit requested · CC0 1.0 Universal

US product labels, adverse event reports (FAERS) and NDC product data.

Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).

https://open.fda.gov/terms/

U.S. Food and Drug Administration

Credit requested · Public domain

Approvals, review documents, shortages, Orange Book and Purple Book listings.

Source: U.S. Food and Drug Administration (https://www.fda.gov).

https://www.fda.gov/about-fda/about-website/website-policies

U.S. Securities and Exchange Commission (EDGAR)

Credit requested · Free to access and reuse

Company filings (10-K, 8-K).

Source: U.S. Securities and Exchange Commission (EDGAR).

https://www.sec.gov/privacy.htm

Open Targets Platform

Credit requested · CC0 1.0

Drug, target and mechanism reference data.

Open Targets Platform. Buniello, A. et al. (2025), Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research.

https://platform-docs.opentargets.org/licence

ChEMBL

Attribution required · Creative Commons Attribution-ShareAlike 3.0 Unported

Drug and mechanism records distributed within the Open Targets Platform.

ChEMBL, EMBL-EBI. Zdrazil, B. et al. (2023), Nucleic Acids Research; Davies, M. et al. (2015), Nucleic Acids Research 43(W1):W612-20. Provided under CC BY-SA 3.0.

https://chembl.gitbook.io/chembl-interface-documentation/about

European Medicines Agency (EMA)

Attribution required · EMA legal notice: reuse permitted when EMA is acknowledged

Assessment reports, product information, registers and committee documents.

Source: European Medicines Agency (https://www.ema.europa.eu). © EMA.

https://www.ema.europa.eu/en/about-us/legal-notice

NHS Business Services Authority (NHSBSA)

Attribution required · Open Government Licence

Drug Tariff and Serious Shortage Protocols.

NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

https://www.nhsbsa.nhs.uk/terms-and-conditions

MHRA and GOV.UK

Attribution required · Open Government Licence v3.0

Drug Safety Update and device alerts.

Contains public sector information licensed under the Open Government Licence v3.0.

https://www.gov.uk/help/terms-conditions

Haute Autorité de santé (HAS)

Attribution required · Free re-use with source and date cited, content unaltered

French opinions, recommendations and decisions.

Document de la Haute Autorité de santé, disponible sur le site www.has-sante.fr

https://www.has-sante.fr/jcms/c_518191/fr/mentions-legales

AOTMiT (Poland)

Attribution required · Use permitted with the source indicated

Polish HTA agency publications.

Source: Agencja Oceny Technologii Medycznych i Taryfikacji (AOTMiT), https://www.aotm.gov.pl

https://www.aotm.gov.pl/prawa-autorskie-3

National Institute for Health and Care Excellence (NICE)

Source acknowledged

Guidance and committee documents.

Source: National Institute for Health and Care Excellence (NICE).

https://www.nice.org.uk

Gemeinsamer Bundesausschuss (G-BA)

Source acknowledged

Benefit assessment decisions and supporting documents.

Source: Gemeinsamer Bundesausschuss (G-BA).

https://www.g-ba.de

Centers for Medicare & Medicaid Services (CMS)

Source acknowledged

Drug pricing and utilisation data.

Source: Centers for Medicare & Medicaid Services (CMS).

https://www.cms.gov

State Medicaid drug utilisation review boards

Source acknowledged

Published board and preferred drug list documents (Illinois, Oregon, Washington).

Source: the respective state Medicaid programmes.

https://www.medicaid.gov

Clinical guideline publishers (NCCN, ESMO, Annals of Oncology)

Source acknowledged

Guideline recommendations.

Source: NCCN, ESMO and Annals of Oncology. Guideline content remains the property of its publishers.

https://www.nccn.org

News and agency feeds

Source acknowledged

Headlines and links from trade publications and regulator feeds, each attributed to its publisher at the item.

Each item names and links to its original publisher.

https://genassis.ai

Questions about a source or a credit: support@genassis.ai